This eye disease often leads to blindness — which might be prevented by early intervention
The team headed by Dr. Jacqueline Reinhard and Prof. Dr. Andreas Faissner from the Department of Cell Morphology and Molecular Neurobiology in Bochum, together with colleagues from the University Eye Clinic in Bochum, RWTH Aachen University, the University of Toronto and the University of Denver, has published a report on their findings. The article was released on 12 October 2018 in the online edition of the journal Molecular Neurobiology.
Specific and early intervention
The researchers bred mice in which the gene PTP-Meg2 (protein tyrosine phosphatase megakaryocyte 2) was mutated . As a result, the animals suffered from chronic intraocular pressure elevation. The team successfully demonstrated that, in their model, the intraocular pressure elevation was associated with a loss of optic nerve fibres and retinal cells. Using functional analyses, they observed that retinal cells were unable to function properly, either. Moreover, they made the following discovery: glial cells and certain components of the immune system showed a reaction in the animals’ optic nerve and retina. As both aspects may be relevant for neurodegeneration, specific and early intervention into these cellular mechanisms may inhibit glaucoma.
Testing new therapy options
Making use of a genetic screening, the researchers subsequently identified new potential biomarkers. In future, these biomarkers may facilitate early detection of glaucoma; as a result, it will be possible to start therapy at an early stage, before the optic nerve and retina are damaged. The glaucoma-mouse model may, moreover, be used to test new therapy options. Experiments to date have shown that intraocular pressure was reduced and nerve cells were retained in the mice if they were given a drug that had been administered to treat human patients.
The Latest on: Glaucoma
via Google News
The Latest on: Glaucoma
- Glaucoma Pharmaceutical Market Revenue and Gross Margin by 2029 | Pfizer, Merck and Allerganon February 1, 2020 at 1:25 am
The continuing growth story of Glaucoma Pharmaceutical Market report consisting of important parts, which present many aspects of the worldwide market with provides more accurate and meaningful ...
- Glaucoma and Cataract Surgery Market- Trends, Analysis and Forecast till 2030on January 31, 2020 at 12:33 am
PMI's Latest Report, Glaucoma and Cataract Surgery Market report is analyzed and studied on the basis of a comprehensive backdrop analysis. Hence, the Global Glaucoma and Cataract Surgery Market ...
- Allergan tackles glaucoma awareness with Super Bowl MVP Von Milleron January 30, 2020 at 1:00 am
Denver Broncos linebacker and Super Bowl 50 MVP Von Miller has teamed up with Allergan to raise awareness for glaucoma. Miller joined Allergan’s MyGlaucoma campaign, which aims to educate people about ...
- UAE-based company ready to export glaucoma medicines to the USon January 28, 2020 at 11:31 am
UAE-based company VPS Healthcare's medicine manufacturing arm, LIFEPharma, has become the first in the region to export Acetazolamide, a medication to treat glaucoma and heart failures, to the US.
- Potent affronEYE® Saffron Extract May Lower Risk of Glaucomaon January 27, 2020 at 4:18 am
MADRID, Jan. 27, 2020 /PRNewswire/ -- A new animal study suggests affronEYE® saffron could help prevent the onset of glaucoma. The antioxidant and anti-inflammatory characteristics of this potent ...
- Glaucoma Awareness Month: Understanding the riskon January 27, 2020 at 1:43 am
January is Glaucoma Awareness Month. The National Eye Institute states glaucoma is the leading cause of preventable blindness, and most individuals are unaware they have the disease. There is no cure ...
- Glaucoma can be treated, so make sure you get screenedon January 26, 2020 at 6:40 pm
Glaucoma is otherwise known as the sneak thief of vision. For the most part, it is a disease that damages the optic nerve of the eye and can rob someone’s peripheral vision slowly and methodically, ...
- Ocular surface disease an important consideration in glaucomaon January 22, 2020 at 6:45 pm
KOLOA, Hawaii — The ocular surface should not be forgotten when managing patients with glaucoma, according to a presenter at Hawaiian Eye 2020. “Glaucoma management causes dry eye and ocular surface ...
- New glaucoma test to help prevent blindnesson January 21, 2020 at 2:41 pm
Researchers have identified 107 genes that increase a person's risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at risk of going blind from it. The ...
via Bing News